Published in
Lippincott, Williams & Wilkins, Current Opinion in Oncology, 6(32), p. 585-593, 2020
DOI: 10.1097/cco.0000000000000680
Links
Tools
Combining poly(ADP-ribose) polymerase inhibitors and immune checkpoint inhibitors in breast cancer: rationale and preliminary clinical results
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 